Aim SM04554, a novel, small molecule Wnt signaling modulator was evaluated in preclinical studies for hair follicle regeneration and hair growth as a potential treatment for AGA.
In CD1 mice, SM04554 induced hair growth with 4-days treatment, with a 2-fold increase (p#0.05) in total hair-follicle counts, compared to vehicle. In depilated C57Bl/6 mice, SM04554 induced hair growth with 10 days of treatment. In C57Bl/6 mice shaved and treated from P49, hair growth was observed after 3 weeks of treatment with SM04554 compared to &5 weeks with vehicle. In NIH-III nude mice, an increase in the number of hair-follicles (2-fold, p#0.05) was observed in SM04554-treated animals on day 14, with appearance of hair on day 28 and further increase with 42 days of treatment compared to no hair growth with vehicle. In mini-pigs, 42 days of SM04554 treatment showed a significant (p#0.05) increase in vellus follicle numbers that was sustained until day 112, as compared to other treatment intervals and vehicle. SM04554 increased total and nuclear β-catenin, versican and Ki-67 specifically in hair follicles compared to vehicle, indicating localized follicular activation of Wnt signaling and proliferation, not generalized to the epidermis.
Conclusion
In rodents and mini-pigs, SM04554 increased follicle number and hair growth compared to vehicle. SM04554 has potential as a topical therapy for AGA. Clinical studies are ongoing.
